The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies.

MLA

Russo, Antonio, et al. “The Challenge of the Molecular Tumor Board Empowerment in Clinical Oncology Practice: A Position Paper on Behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies.” Critical Reviews in Oncology/Hematology, vol. 169, Jan. 2022, p. 103567. EBSCOhost, https://doi.org/10.1016/j.critrevonc.2021.103567.

APA

Russo, A., Incorvaia, L., Capoluongo, E., Tagliaferri, P., Galvano, A., Del Re, M., Malapelle, U., Chiari, R., Conte, P., Danesi, R., Fassan, M., Ferrara, R., Genuardi, M., Ghiorzo, P., Gori, S., Guadagni, F., Marchetti, A., Marchetti, P., Midiri, M., … Beretta, G. (2022). The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies. Critical Reviews in Oncology/Hematology, 169, 103567. https://doi.org/10.1016/j.critrevonc.2021.103567

Chicago

Russo, Antonio, Lorena Incorvaia, Ettore Capoluongo, Pierosandro Tagliaferri, Antonio Galvano, Marzia Del Re, Umberto Malapelle, et al. 2022. “The Challenge of the Molecular Tumor Board Empowerment in Clinical Oncology Practice: A Position Paper on Behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific Societies.” Critical Reviews in Oncology/Hematology 169 (January): 103567. doi:10.1016/j.critrevonc.2021.103567.